Description
Indication & Scope
Merislon® Betahistine Mesilate Tablets improves inner ear blood circulation, relieve dizziness and vertigo symptoms caused by Meniere’s disease and vertigo syndrome.
- Mechanism: Dilate inner ear microvessels, improve inner ear and cerebral microcirculation disorders, reduce lymphatic pressure in inner ear labyrinth, and eliminate vertigo and tinnitus symptoms.
- Drug class: Microcirculation improver and anti-vertigo drug.
- Clinical use: Clinically applied for symptomatic treatment of vertigo, dizziness and tinnitus caused by Meniere’s disease, vestibular vertigo and cerebral circulation insufficiency.
| Generic Name | Betahistine Mesilate Tablets |
| Brand Name | Merislon® |
| Ingredient | Betahistine Mesilate |
| Dosage Form | Tablets |
| Package | 6 mg* 10 tablets* 10 blisters/box
6 mg* 10 tablets* 3 blisters/box |
| Conditions Treated | Meniere’s disease, vestibular vertigo syndrome, inner ear circulation disorder dizziness |
| Taboos | Contraindicated for patients with pheochromocytoma, peptic ulcer, bronchial asthma and hypersensitivity to betahistine mesylate |
| Place of origin | China |
| Prescription type | Prescription-only |
| Storage Conditions | Seal tightly, store in a cool dry place, avoid light |
| Manufacturer | Eisai (China) Pharmaceutical Co., Ltd |
| Registration Authority | National Medical Products Administration (NMPA), China |
| Approval number | H20040130 |
| Approval Date | Jun 9, 2025 |
| Shelf Life | 24 months |
How to use ?
Recommended Dose: 1 to 2 tablets per time, 3 times a day, adjust dosage according to symptom severity.
Time: Take orally after meals.
Instructions for use: Discontinue use and seek medical advice if symptoms do not improve after continuous medication; regular reexamination is required for chronic vertigo patients.
Interaction: No obvious adverse drug interactions; avoid combined use with antihistamine drugs.
Side effects: Mild gastrointestinal discomfort such as nausea and abdominal distension; occasional headache and skin itching.
Important Notice
This product should be administered only by qualified healthcare professionals in accordance with the approved prescribing information and local clinical guidelines. Dosage and administration may vary depending on patient condition, indicatiaon, and regional regulatory requirements.
Packaging & Shipping
Packaging
Original manufacturer’s packaging with secure export carton. Customized export packaging is available upon request.
Shipping Methods
Express Courier (EMS, DHL, FedEx, UPS), Air Freight, and Sea Freight. Cold-chain transportation is available for products requiring temperature-controlled logistics.
Export Support
Certificate of Analysis
GMP Certificate
Commercial Invoice
Packing List & CPP
Cold Chain Logistics
Customs Documentation
Scientific and regulatory sources
FAQ
What main symptoms can Betahistine Mesilate Tablets this anti-vertigo drug relieve?
This drug can effectively relieve dizziness and vertigo symptoms caused by Meniere’s disease and various vertigo syndromes.
What is the core therapeutic principle of Betahistine Mesilate Tablets for vertigo?
This drug treats vertigo by dilating inner ear microvessels and improving inner ear and cerebral blood circulation.
Which patients are prohibited from taking Betahistine Mesilate Tablets?
Patients with peptic ulcer, bronchial asthma, pheochromocytoma and drug allergy are prohibited from use.
What mild adverse reactions may occur during medication of Betahistine Mesilate Tablets?
Mild gastrointestinal nausea, abdominal distension and occasional headache and skin itching may occur.
Merislon® | Betahistine Mesilate Tablets | Relieve Meniere’s Disease and Dizziness | DengYueRX
INN: Betahistine Mesilate Tablets
Indications: Relieve Meniere’s disease and dizziness
Dosage Form: Tablets
Strength: 6 mg/Tablet
Price range: $3.09 through $9.06
